Home / Stocks / Shalby Limited
SHALBY

Shalby Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹121.89

Change

+2.93 (2.46%)

Open

₹118.66

Prev. Close

₹118.96

Day High

₹123.3

Day Low

₹118.0

Volume Analysis

Traded

71,339

Delivered

41,206

Delivery %

57.76%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (2)

  • •Low return on equity (2.45%)
  • •Below-average fundamentals quality score (40/100)

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹129.42 ₹126.36 ₹124.12 ₹121.06 ₹118.82 ₹115.76 ₹113.52
Fibonacci ₹126.36 ₹124.34 ₹123.08 ₹121.06 ₹119.04 ₹117.78 ₹115.76
Camarilla ₹123.35 ₹122.86 ₹122.38 ₹121.06 ₹121.4 ₹120.92 ₹120.43

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-39.94%

1 Week

-4.29%

1 Month

+1.09%

3 Months

-20.31%

6 Months

-28.69%

1 Year

-45.15%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹85.82

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

3.51%

Net margin 3.16% × asset turnover 0.61x × equity multiplier 1.82x

Company Overview

Sector

Healthcare

Market Cap

₹1,317 Cr

P/E (TTM)

33.6

ROE

2.45%

Book Value

₹94.6

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 20 Nov 2026. Not investment advice.

TopFund Analysis

Shalby Limited scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 40/100. The strongest factor is Financial Strength (84/100), while Cash Flow (0/100) is the weakest area to weigh before deciding. Notably: Low return on equity (2.45%); below-average fundamentals quality score (40/100).

TopFund Score — Fundamentals Quality

40/100 — Weak

Data confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

84

Growth

40

Valuation

39

Cash Flow

0

Corporate Governance

56

Momentum

10

Institutional Ownership

34

Business Quality

39

Risk & Volatility

30

Liquidity

39

From Screener.in

  • +Company's working capital requirements have reduced from 32.0 days to 21.7 days
  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −Company has a low return on equity of 3.11% over last 3 years.
  • −Dividend payout has been low at 5.11% of profits over last 3 years

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Earnings Call Transcript - conference call held on 04-Nov-2026

Newspaper publication for Postal Ballot notice and remote e-voting

Shalby revises Tushar Shah’s designation after his Executive Director appointment; no change in authorised personnel.

Shalby shared the audio recording of its Q2 FY2027 earnings conference call.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 238 216 244 279 268 276 265 296 285 272 287 331 313
Expenses + 185 174 205 234 235 242 244 255 244 242 258 290 272
Operating Profit 53 42 39 45 33 34 21 42 42 30 29 42 41
OPM % 22.15% 19.59% 15.91% 16.21% 12.2% 12.3% 7.87% 14.01% 14.58% 11.12% 10.21% 12.56% 13.22%
Other Income + 5 5 5 10 7 5 5 7 4 7 8 7 5
Interest 3 4 6 8 9 11 11 9 10 11 9 11 11
Depreciation 12 12 16 16 17 16 16 17 17 18 18 19 19
Profit before tax 43 31 22 30 14 12 -1 23 19 9 10 20 16
Tax % 35.3% 38.14% 26.35% 51.55% 82.71% 124.21% 1,547.3% 66.09% 61.88% 86.13% -92.19% 46.7% 52.16%
Net Profit + 28 19 16 15 2 -3 -12 8 7 1 18 11 8
EPS in Rs 3 2 2 1 0 0 -1 1 1 0 2 1 1
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 18 7 23 18 12 28 8 6 7 -1 9 12 10

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 275 290 324 378 462 487 431 699 805 934 1,087 1,141 1,204
Expenses + 207 235 252 299 379 404 342 577 667 755 952 996 1,061
Operating Profit 68 56 71 79 83 83 89 122 138 179 135 145 143
OPM % 25.0% 19.0% 22.0% 21.0% 18.0% 17.0% 21.0% 17.0% 17.0% 19.0% 12.0% 13.0% 12.0%
Other Income + 2 2 7 10 9 17 8 8 22 19 28 27 28
Interest 5 10 11 12 9 7 5 8 11 18 41 41 42
Depreciation 21 11 17 23 33 36 37 43 48 52 66 70 74
Profit before tax 43 36 50 54 50 57 55 79 102 128 56 61 55
Tax % 43.0% -1.0% 43.0% 27.0% 37.0% 51.0% 23.0% 32.0% 34.0% 35.0% 97.0% 43.0% —
Net Profit + 25 36 29 39 32 28 42 54 68 84 2 35 38
EPS in Rs 3 4 3 4 3 3 4 5 6 8 1 3 4
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 17.0% 20.0% 25.0% 20.0% 19.0% 15.0% 0.0% 0.0% —
Sales growth 6 5 11 17 22 5 -11 62 15 16 16 5 7

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 133 117 164 643 672 691 727 768 820 893 885 898 915
Borrowings + 98 224 328 114 71 62 44 155 180 378 476 595 585
Other Liabilities + 85 75 99 96 89 105 118 162 173 231 241 248 249
Total Liabilities 351 504 679 961 939 967 997 1,194 1,281 1,609 1,709 1,848 1,857
Fixed Assets + 175 319 323 650 692 672 660 675 685 966 955 1,046 1,049
CWIP 91 82 221 47 3 6 8 6 11 15 22 19 1
Investments 0 0 0 0 11 28 16 25 146 81 95 62 48
Other Assets + 85 102 134 264 233 260 314 488 440 547 637 721 760
Total Assets 351 504 679 961 939 967 997 1,194 1,281 1,609 1,709 1,848 1,857
Equity Capital 35 87 87 108 108 108 108 108 107 107 107 108 108

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + — — 60 14 43 55 79 19 68 20 -4 0
Cash from Investing Activity + — — -153 -236 1 -31 -51 -60 -61 146 -36 -97
Cash from Financing Activity + — — 96 222 -51 -22 -30 90 -50 -151 48 84
Net Cash Flow — — 3 0 -6 3 -2 49 -43 15 8 -13
Free Cash Flow — — -98 -124 12 244 58 -56 50 -26 -74 -145
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit — — 99 34 63 91 99 34 70 22 7 27

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 74.12% → 74.33%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Others 0.83% 0.76% 0.7% 0.69% 0.69% 0.69% 0.69% 0.66% 0.66% 0.66% 0.65% 0.62%
Public 20.42% 20.13% 19.65% 19.59% 20.26% 20.33% 19.65% 20.18% 20.36% 20.41% 20.26% 20.08%
Promoters 74.12% 74.24% 74.25% 74.25% 74.27% 74.27% 74.27% 74.33% 74.33% 74.33% 74.33% 74.33%
FII 4.62% 4.88% 5.35% 5.37% 4.65% 4.54% 5.21% 4.63% 4.47% 4.36% 4.47% 4.65%
DII 0.0% 0.0% 0.06% 0.09% 0.14% 0.18% 0.19% 0.19% 0.19% 0.25% 0.3% 0.31%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Shalby Limited (this stock) 1,317 33.6 1.29 2.45%
Anlon Healthcare Limited 1,348 37.8 5.25 18.4%
Kopran Ltd 1,281 32.6 2.44 4.91%
Gujarat Kidney N Sup Sp L 1,269 66.8 4.82 11.1%
Fermenta Biotech Ltd. 1,367 29.4 3.27 17.3%
Jagsonpal Pharmaceuticals 1,402 — 5.82 —
Amrutajan Health Ltd 1,461 71.7 13.58 20.0%

Which Mutual Funds Hold Shalby Limited?

Frequently Asked Questions about Shalby Limited

Community Sentiment

What are other investors saying about Shalby Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.